Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-11-28 3:59 pm Purchase | 2022-11-17 | 13G | Acrivon Therapeutics, Inc. Common Stock ACRV | Chione Ltd. | 3,856,597 18.500% | 3,856,597 (New Position) | Filing History |
| 2022-11-25 4:25 pm Purchase | 2022-11-15 | 13G | Acrivon Therapeutics, Inc. Common Stock ACRV | Sands Capital Life Sciences Pulse Fund II L.P. | 1,652,606 7.900% | 1,652,606 (New Position) | Filing History |
| 2022-11-21 4:01 pm Purchase | 2022-11-09 | 13G | Acrivon Therapeutics, Inc. Common Stock ACRV | Citadel Advisors LLC | 1,634,637 7.800% | 1,634,637 (New Position) | Filing History |
| 2022-11-18 4:31 pm Purchase | 2022-11-17 | 13G | Acrivon Therapeutics, Inc. Common Stock ACRV | Perceptive Advisors LLC | 3,007,858 14.400% | 3,007,858 (New Position) | Filing History |